BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 19 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $701,000 | +61.1% | 17,900 | -6.6% | 0.00% | +50.0% |
| Q2 2020 | $435,000 | +197.9% | 19,160 | +1.2% | 0.00% | +100.0% |
| Q1 2020 | $146,000 | -7.0% | 18,935 | +12.7% | 0.00% | 0.0% |
| Q4 2019 | $157,000 | +63.5% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $96,000 | -1.0% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $97,000 | +6.6% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $91,000 | +12.3% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $81,000 | -13.8% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $94,000 | -16.1% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $112,000 | +23.1% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $91,000 | 0.0% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $91,000 | – | 16,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
| MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
| Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
| BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
| NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
| ARK Investment Management | 19,856 | $776,000 | 0.01% |
| HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
| Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |